Simvastatin equivalent dose | 1st quartile (10 – 30 mg), n = 28 | 2nd quartile (31 – 40 mg), n = 22 | 3rd quartile (41 – 80 mg), n = 23 | 4th quartile (81 – 336 mg), n = 14 |
---|---|---|---|---|
Age (years) | 82.3 (6.4) | 81.0 (5.8) | 81.0 (6.7) | 78.4 (6.6) |
Female, n (%) | 18 (64) | 12 (55) | 12 (52) | 6 (43) |
BMI (kg/m2) a | 24.7 (4.9) | 25.9 (5.7) | 26.7 (5.7) | 29.4 (5.6) |
CIRS (0-56) | 16.9 (4.0) | 16.8 (4.8) | 17.3 (4.3) | 18.0 (3.8) |
FIM (18-126) | 111.4 (12.5) | 111.4 (10.4) | 114.3 (9.1) | 108.6 (12.7) |
CDR (0-18) | 2.3 (3.6) | 1.3 (2.2) | 1.9 (2.7) | 4.1 (4.9) |
Grip strength (kg) | 21.0 (9.6) | 18.3 (6.9) | 22.8 (7.4) | 24.9 (7.9) |
Grip strength indicating sarcopenia b, n (%) | 12 (43) | 17 (77) | 11 (48) | 4 (29) |
SPPB (0-12) | 4.2 (3.1) | 3.9 (2.8) | 5.4 (2.9) | 6.1 (3.8) |
SPPB ≤8, n (%) | 24 (86) | 21 (96) | 21 (91) | 9 (64) |
Gait speed (m/s) c | 0.65 (0.20) | 0.58 (0.19) | 0.65 (0.16) | 0.71 (0.22) |
Gait speed ≤0.8 m/s, n (%) | 18 (72) | 17 (85) | 18 (82) | 7 (54) |